| scholarly article | Q13442814 |
| P2093 | author name string | J J Sauk | |
| N G Nikitakis | |||
| H Siavash | |||
| P2860 | cites work | Principles of interleukin (IL)-6-type cytokine signalling and its regulation | Q24530173 |
| Serine phosphorylation and negative regulation of Stat3 by JNK | Q28145918 | ||
| The MKK6/p38 mitogen-activated protein kinase pathway is capable of inducing SOCS3 gene expression and inhibits IL-6-induced transcription | Q28208036 | ||
| Cyclopentenone prostaglandins: new insights on biological activities and cellular targets | Q28619819 | ||
| STATs and gene regulation | Q29547796 | ||
| STATs in oncogenesis | Q29617571 | ||
| JAKs, STATs and Src kinases in hematopoiesis | Q31063082 | ||
| A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPARgamma | Q31938741 | ||
| SOCS: suppressors of cytokine signalling | Q31994132 | ||
| Negative regulation of the JAK/STAT pathway | Q33539658 | ||
| Physiological significance of STAT proteins: investigations through gene disruption in vivo | Q33754086 | ||
| The role of STATs in transcriptional control and their impact on cellular function | Q33941346 | ||
| STAT signaling in head and neck cancer | Q33941351 | ||
| Activation of STAT proteins and growth control | Q34136104 | ||
| STAT proteins: novel molecular targets for cancer drug discovery | Q34293579 | ||
| Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor | Q34379342 | ||
| Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention | Q34595904 | ||
| Stat proteins and oncogenesis | Q34627064 | ||
| Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo | Q35676433 | ||
| Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines | Q36239779 | ||
| Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases | Q36307242 | ||
| Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro | Q37385294 | ||
| Differential function of STAT5 isoforms in head and neck cancer growth control | Q38289837 | ||
| 15-PGJ2, but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes downregulation of Stat3 in human oral SCCa cells | Q38292542 | ||
| Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity | Q38312043 | ||
| Src kinases mediate STAT growth pathways in squamous cell carcinoma of the head and neck | Q38354192 | ||
| MAP kinase cascades are activated in astrocytes and preadipocytes by 15-deoxy-Delta(12-14)-prostaglandin J(2) and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor gamma-independent mechanisms involving reactive ox | Q40726966 | ||
| Inhibition of IL-6 and IL-10 signaling and Stat activation by inflammatory and stress pathways | Q40846598 | ||
| LPS and TNFalpha induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages. | Q40910796 | ||
| Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells | Q40925778 | ||
| Effects of interleukin-1alpha, interleukin-1 receptor antagonist, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines. | Q41012233 | ||
| Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-delta12,14-prostaglandin J2. | Q42483553 | ||
| Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress | Q43559588 | ||
| Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells | Q43649346 | ||
| 15-deoxy-Delta 12,14-prostaglandin J2 induces apoptosis of human hepatic myofibroblasts. A pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors. | Q43690457 | ||
| Early de novo gene expression is required for 15-deoxy-Delta 12,14-prostaglandin J2-induced apoptosis in breast cancer cells | Q43773214 | ||
| Autocrine-mediated activation of STAT3 correlates with cell proliferation in breast carcinoma lines | Q43891663 | ||
| Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cells | Q43955953 | ||
| 15-Deoxy-delta12,14-prostaglandin J2-induced apoptosis does not require PPARgamma in breast cancer cells | Q44195479 | ||
| 15d-PGJ2 and rosiglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in glia | Q44313350 | ||
| Involvement of c‐jun N‐terminal kinase activation in 15‐deoxy‐δ12,14‐prostaglandin J2–and prostaglandin A1–induced apoptosis in AGS gastric epithelial cells | Q44421564 | ||
| Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system. | Q53654970 | ||
| Prostaglandin A2 and delta 12-prostaglandin J2 induce apoptosis in L1210 cells | Q70670010 | ||
| Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines | Q73042572 | ||
| Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer | Q73519290 | ||
| Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells | Q73574304 | ||
| JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells | Q74121752 | ||
| STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor growth in vivo | Q74649686 | ||
| The role of c-Myc and heat shock protein 70 in human hepatocarcinoma Hep3B cells during apoptosis induced by prostaglandin A2/Delta12-prostaglandin J2 | Q77587342 | ||
| Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer | Q77948466 | ||
| 15-Deoxy-Delta(12,14)-prostaglandin J(2), a ligand for peroxisome proliferator-activated receptor-gamma, induces apoptosis in JEG3 choriocarcinoma cells | Q78202614 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1074-1080 | |
| P577 | publication date | 2004-09-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Abrogation of IL-6-mediated JAK signalling by the cyclopentenone prostaglandin 15d-PGJ(2) in oral squamous carcinoma cells | |
| P478 | volume | 91 |
| Q39197422 | 15-Deoxy-Δ12,14-Prostaglandin J2 Modifies Components of the Proteasome and Inhibits Inflammatory Responses in Human Endothelial Cells |
| Q35148085 | Induction of BCL2-Interacting Killer, BIK, is Mediated for Anti-Cancer Activity of Curcumin in Human Head and Neck Squamous Cell Carcinoma Cells |
| Q35060321 | Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma |
| Q28292907 | Omega-3 Fatty Acids and PPARgamma in Cancer |
| Q39882795 | Sustained Src inhibition results in signal transducer and activator of transcription 3 (STAT3) activation and cancer cell survival via altered Janus-activated kinase-STAT3 binding |
| Q34605234 | The oncogenic effects of constitutive Stat3 signaling in salivary gland cancer cells are mediated by survivin and modulated by the NSAID sulindac |
Search more.